Voluntis Announces Its First Contract with a US Payer, WellDyneRx, for Coverage of a Digital Therapeutic
Voluntis’ Insulia® will be incorporated into the recently-launched WellManaged-Diabetes program.
Pharmacy Benefit Manager Creates Innovative Program for Diabetes Care
Publication interviews WellDyneRx’s Patty Taddei-Allen, PharmD, BCACP, BCGP, Director, Outcomes Research
WellDyneRx Launches Revitalized Website, Rebrand to Better Serve Clients and Members
Independent PBM focuses on “Every Little Thing” and the commitment to control costs while improving…